Skip to main content
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1992 Aug;141(2):271–277.

The primary structure of the prion protein influences the distribution of abnormal prion protein in the central nervous system.

T Kitamoto 1, K Doh-ura 1, T Muramoto 1, M Miyazono 1, J Tateishi 1
PMCID: PMC1886604  PMID: 1353945

Abstract

We immunohistochemically examined tissue sections from patients with prion protein (PrP) polymorphism using hydrolytic autoclaving enhancement. Abnormal PrP accumulations could be classified into plaque formations (plaque-type) and the diffuse gray matter stainings including synaptic structures (synaptic-type). Insertional polymorphism, a point mutation in codon 102 or 117/129, and a polymorphism in codon 129 (Val129) result in plaque-type PrP accumulations. The patients with codon 102 mutation also have synaptic-type PrP accumulations. However, a point mutation in codon 200 did not show plaque-type accumulations, and only showed synaptic-type PrP accumulations. Likewise, sporadic Creutzfeldt-Jakob disease patients without any known mutations only have synaptic type accumulations. These results imply that the primary structures of PrP influence the phenotype of prion diseases, especially in abnormal PrP distributions of the central nervous system.

Full text

PDF
271

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Collinge J., Harding A. E., Owen F., Poulter M., Lofthouse R., Boughey A. M., Shah T., Crow T. J. Diagnosis of Gerstmann-Sträussler syndrome in familial dementia with prion protein gene analysis. Lancet. 1989 Jul 1;2(8653):15–17. doi: 10.1016/s0140-6736(89)90256-0. [DOI] [PubMed] [Google Scholar]
  2. Collinge J., Owen F., Poulter M., Leach M., Crow T. J., Rossor M. N., Hardy J., Mullan M. J., Janota I., Lantos P. L. Prion dementia without characteristic pathology. Lancet. 1990 Jul 7;336(8706):7–9. doi: 10.1016/0140-6736(90)91518-f. [DOI] [PubMed] [Google Scholar]
  3. Doh-ura K., Kitamoto T., Sakaki Y., Tateishi J. CJD discrepancy. Nature. 1991 Oct 31;353(6347):801–802. doi: 10.1038/353801b0. [DOI] [PubMed] [Google Scholar]
  4. Doh-ura K., Tateishi J., Kitamoto T., Sasaki H., Sakaki Y. Creutzfeldt-Jakob disease patients with congophilic kuru plaques have the missense variant prion protein common to Gerstmann-Sträussler syndrome. Ann Neurol. 1990 Feb;27(2):121–126. doi: 10.1002/ana.410270205. [DOI] [PubMed] [Google Scholar]
  5. Doh-ura K., Tateishi J., Sasaki H., Kitamoto T., Sakaki Y. Pro----leu change at position 102 of prion protein is the most common but not the sole mutation related to Gerstmann-Sträussler syndrome. Biochem Biophys Res Commun. 1989 Sep 15;163(2):974–979. doi: 10.1016/0006-291x(89)92317-6. [DOI] [PubMed] [Google Scholar]
  6. Goldfarb L. G., Brown P., Goldgaber D., Garruto R. M., Yanagihara R., Asher D. M., Gajdusek D. C. Identical mutation in unrelated patients with Creutzfeldt-Jakob disease. Lancet. 1990 Jul 21;336(8708):174–175. doi: 10.1016/0140-6736(90)91693-5. [DOI] [PubMed] [Google Scholar]
  7. Goldfarb L. G., Haltia M., Brown P., Nieto A., Kovanen J., McCombie W. R., Trapp S., Gajdusek D. C. New mutation in scrapie amyloid precursor gene (at codon 178) in Finnish Creutzfeldt-Jakob kindred. Lancet. 1991 Feb 16;337(8738):425–425. doi: 10.1016/0140-6736(91)91198-4. [DOI] [PubMed] [Google Scholar]
  8. Goldfarb L. G., Korczyn A. D., Brown P., Chapman J., Gajdusek D. C. Mutation in codon 200 of scrapie amyloid precursor gene linked to Creutzfeldt-Jakob disease in Sephardic Jews of Libyan and non-Libyan origin. Lancet. 1990 Sep 8;336(8715):637–638. doi: 10.1016/0140-6736(90)93443-s. [DOI] [PubMed] [Google Scholar]
  9. Goldfarb L. G., Mitrová E., Brown P., Toh B. K., Gajdusek D. C. Mutation in codon 200 of scrapie amyloid protein gene in two clusters of Creutzfeldt-Jakob disease in Slovakia. Lancet. 1990 Aug 25;336(8713):514–515. doi: 10.1016/0140-6736(90)92073-q. [DOI] [PubMed] [Google Scholar]
  10. Goldmann W., Hunter N., Benson G., Foster J. D., Hope J. Different scrapie-associated fibril proteins (PrP) are encoded by lines of sheep selected for different alleles of the Sip gene. J Gen Virol. 1991 Oct;72(Pt 10):2411–2417. doi: 10.1099/0022-1317-72-10-2411. [DOI] [PubMed] [Google Scholar]
  11. Hsiao K. K., Scott M., Foster D., Groth D. F., DeArmond S. J., Prusiner S. B. Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science. 1990 Dec 14;250(4987):1587–1590. doi: 10.1126/science.1980379. [DOI] [PubMed] [Google Scholar]
  12. Hsiao K., Baker H. F., Crow T. J., Poulter M., Owen F., Terwilliger J. D., Westaway D., Ott J., Prusiner S. B. Linkage of a prion protein missense variant to Gerstmann-Sträussler syndrome. Nature. 1989 Mar 23;338(6213):342–345. doi: 10.1038/338342a0. [DOI] [PubMed] [Google Scholar]
  13. Kitamoto T., Muramoto T., Hilbich C., Beyreuther K., Tateishi J. N-terminal sequence of prion protein is also integrated into kuru plaques in patients with Gerstmann-Sträussler syndrome. Brain Res. 1991 Apr 5;545(1-2):319–321. doi: 10.1016/0006-8993(91)91306-l. [DOI] [PubMed] [Google Scholar]
  14. Kitamoto T., Muramoto T., Mohri S., Doh-Ura K., Tateishi J. Abnormal isoform of prion protein accumulates in follicular dendritic cells in mice with Creutzfeldt-Jakob disease. J Virol. 1991 Nov;65(11):6292–6295. doi: 10.1128/jvi.65.11.6292-6295.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kitamoto T., Ogomori K., Tateishi J., Prusiner S. B. Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. Lab Invest. 1987 Aug;57(2):230–236. [PubMed] [Google Scholar]
  16. Kitamoto T., Shin R. W., Doh-ura K., Tomokane N., Miyazono M., Muramoto T., Tateishi J. Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt-Jakob disease. Am J Pathol. 1992 Jun;140(6):1285–1294. [PMC free article] [PubMed] [Google Scholar]
  17. Kitamoto T., Tateishi J. Immunohistochemical confirmation of Creutzfeldt-Jakob disease with a long clinical course with amyloid plaque core antibodies. Am J Pathol. 1988 Jun;131(3):435–443. [PMC free article] [PubMed] [Google Scholar]
  18. Kitamoto T., Tateishi J., Tashima T., Takeshita I., Barry R. A., DeArmond S. J., Prusiner S. B. Amyloid plaques in Creutzfeldt-Jakob disease stain with prion protein antibodies. Ann Neurol. 1986 Aug;20(2):204–208. doi: 10.1002/ana.410200205. [DOI] [PubMed] [Google Scholar]
  19. Kitamoto T., Yamaguchi K., Doh-ura K., Tateishi J. A prion protein missense variant is integrated in kuru plaque cores in patients with Gerstmann-Sträussler syndrome. Neurology. 1991 Feb;41(2 ):306–310. doi: 10.1212/wnl.41.2_part_1.306. [DOI] [PubMed] [Google Scholar]
  20. Lowenstein D. H., Butler D. A., Westaway D., McKinley M. P., DeArmond S. J., Prusiner S. B. Three hamster species with different scrapie incubation times and neuropathological features encode distinct prion proteins. Mol Cell Biol. 1990 Mar;10(3):1153–1163. doi: 10.1128/mcb.10.3.1153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Muramoto T., Kitamoto T., Tateishi J., Goto I. The sequential development of abnormal prion protein accumulation in mice with Creutzfeldt-Jakob disease. Am J Pathol. 1992 Jun;140(6):1411–1420. [PMC free article] [PubMed] [Google Scholar]
  22. Owen F., Poulter M., Shah T., Collinge J., Lofthouse R., Baker H., Ridley R., McVey J., Crow T. J. An in-frame insertion in the prion protein gene in familial Creutzfeldt-Jakob disease. Brain Res Mol Brain Res. 1990 Apr;7(3):273–276. doi: 10.1016/0169-328x(90)90038-f. [DOI] [PubMed] [Google Scholar]
  23. Palmer M. S., Dryden A. J., Hughes J. T., Collinge J. Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature. 1991 Jul 25;352(6333):340–342. doi: 10.1038/352340a0. [DOI] [PubMed] [Google Scholar]
  24. Prusiner S. B. Molecular biology of prion diseases. Science. 1991 Jun 14;252(5012):1515–1522. doi: 10.1126/science.1675487. [DOI] [PubMed] [Google Scholar]
  25. Prusiner S. B. Novel proteinaceous infectious particles cause scrapie. Science. 1982 Apr 9;216(4542):136–144. doi: 10.1126/science.6801762. [DOI] [PubMed] [Google Scholar]
  26. Tateishi J., Kitamoto T., Doh-ura K., Sakaki Y., Steinmetz G., Tranchant C., Warter J. M., Heldt N. Immunochemical, molecular genetic, and transmission studies on a case of Gerstmann-Sträussler-Scheinker syndrome. Neurology. 1990 Oct;40(10):1578–1581. doi: 10.1212/wnl.40.10.1578. [DOI] [PubMed] [Google Scholar]
  27. Tateishi J., Kitamoto T., Hashiguchi H., Shii H. Gerstmann-Sträussler-Scheinker disease: immunohistological and experimental studies. Ann Neurol. 1988 Jul;24(1):35–40. doi: 10.1002/ana.410240108. [DOI] [PubMed] [Google Scholar]
  28. Yost C. S., Lopez C. D., Prusiner S. B., Myers R. M., Lingappa V. R. Non-hydrophobic extracytoplasmic determinant of stop transfer in the prion protein. Nature. 1990 Feb 15;343(6259):669–672. doi: 10.1038/343669a0. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES